gold has been researched along with Ovarian Neoplasms in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (4.95) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 51 (50.50) | 24.3611 |
2020's | 45 (44.55) | 2.80 |
Authors | Studies |
---|---|
Choe, HS; Choi, KU; Kim, DK; Kim, JH; Kwon, SG; Lee, H; Shin, MJ | 1 |
Cui, M; Duan, S; Guo, Y; Li, N; Li, Q; Wang, X; Wang, Y; Xiong, T; Zhu, L | 1 |
Aydin, O; Kip, B; Tunc, CU | 1 |
Bai, Y; Chen, C; He, F; Hu, C; Li, S; Li, W; Ming, D; Ni, G; Tan, CS; Zhang, J | 1 |
Brooker, J; Cramer, DW; Elias, KM; Evans, C; Fülöp, V; González, G; Hansen, WP; Hoballah, J; Jeong, S; Konstantinopoulos, PA; Krauledat, P; Lakatos, K; Patankar, M | 1 |
Chen, D; Gooding, JJ; Tilley, RD; Wu, Y | 1 |
Chen, J; Shen, Y; Wang, H; Wang, M; Zhou, J | 1 |
Amoresano, A; Carpentieri, A; Fiaschi, T; Gamberi, T; Magherini, F; Massai, L; Melchiorre, C; Messori, L; Modesti, A | 1 |
Quintana, M; Rodriguez-Rius, A; Sanz Miguel, PJ; Triola, G; Vellé, A; Vives, S | 1 |
Clack, K; Kasetsirikul, S; Kline, R; Salomon, C; Shiddiky, MJA; Soda, N | 1 |
Cahill, HF; MacCormack, TJ; McDougall, RM; Meli, MV; Power, ME; Rourke, JL | 1 |
Belcher, AM; Berggren, KK; Chen, C; Colangelo, M; He, Y; Huang, S; Lin, CW; Wong, FNC | 1 |
Cirri, D; Gabbiani, C; Giacomelli, C; Guerri, A; Massai, L; Messori, L; Pratesi, A; Trincavelli, ML | 1 |
Asfa, S; Bhattacharya, R; Bieniasz, M; Dey, A; Dwivedi, SKD; Elechalwar, CK; Fung, KM; Gulla, SK; Hossen, MN; Mukherjee, P; Rao, G; Robertson, JD; Sheth, V; Wang, L; Wilhelm, S; Xu, C; Zhang, Y | 1 |
Kashtiaray, A; Maleki, A; Taheri-Ledari, R; Zarei-Shokat, S; Zolfaghari, E | 1 |
Asl, SS; Noorbazargan, H; Tafvizi, F | 1 |
Baachaoui, S; Habel, A; Meftah, M; Raouafi, N; Yaacoubi-Loueslati, B | 1 |
AbdElgawad, H; Abumiya, M; Akamine, Y; Al-Hussinan, NM; Alanazi, A; Alanazi, N; Albert, PS; Alghamdi, KA; Alqahtani, M; Alrubaia, W; Alzhrani, M; Andonian, C; Antonioli, E; Aron, J; Asard, H; Asmara, AAGY; Azimonti, G; Bai, W; Bampidis, V; Barham, JP; Basile, R; Bastos, ML; Batista, E; Batista, MFDS; Bebber, F; Beemster, GTS; Benarous, X; Bertolucci, C; Boissel, L; Bonnay, C; Brantom, P; Brocheton, C; Campos, G; Carula, BC; Channmgere Govindappa, S; Chen, LZ; Chen, Z; Cheng, R; Chesson, A; Christensen, H; Cohen, M; Crovetto, C; Cui, X; D'Aniello, S; Dasari, S; Debieux, P; Degasperi, FA; Deligne, LM; Demeyer, S; Deng, T; Deslivia, MF; Dolphin, AC; Du, P; Dusemund, B; Falótico, GG; Fang, JG; Fašmon Durjava, M; Feng, SZ; Ferretti, M; Fischer, N; Foulon, A; Franco, N; Frigato, E; Fu, GM; Fukushi, Y; Gao, B; Gao, M; Gao, PF; Gao, S; Gatto, E; Ge, N; Giostri, GS; Goldberg, SD; Gondry, J; Gonzalez, P; Gribble, MO; Gries, KJ; Gschwind, RM; Guilé, JM; Guo, FL; Guo, Z; Hart, CR; He, JW; Hornbacher, J; Hou, HZ; Hou, XK; Hu, T; Huang, CZ; Huang, DM; Huang, Q; Huang, R; Jiang, D; Jin, Y; Kaleka, CC; Kameoka, Y; Kang, M; Kanokmedhakul, S; Karna, MB; Kashoo, F; Kavetska, O; Kim, E; Kouba, M; Kunz, HE; Laarmann, T; Lahaye, H; Lai, JM; Lanza, IR; Li, J; Li, LJ; Li, R; Li, SN; Li, X; Li, Y; Lin, K; Liu, JJ; Liu, Y; López Puente, S; López-Alonso, M; Lu, K; Lucon-Xiccato, T; Ma, K; Ma, L; Machado, TLA; Mandigma, MJP; Manini, P; Marcon, F; Markakis, MN; Martins, LL; Mayo, B; Meregawa, PF; Miraj, M; Miura, M; Möller, T; Montalbano, G; Muthusamy, H; Nara, M; Novak, EM; Ou, H; Papenbrock, J; Parvizi, M; Pechová, A; Pellegrino, O; Perez, HL; Petkova, M; Phaosiri, C; Pizzo, F; Potts, D; Qi, G; Qi, H; Qu, H; Qu, T; Ramgoolam, KH; Ramos, F; Ranjitkar, S; Ren, X; Ribeiro, AS; Romero, V; Ruan, XH; Ryan, Z; Samankul, A; Sanz, Y; Scatigna, BF; Senawong, G; Senawong, T; Seyam, MK; Shahin, A; Shi, H; Shi, Q; Shi, W; Silva, FBD; Sirajudeen, MS; Smith, I; Sousa, JA; Sripa, B; Stockerl, WJ; Swatsitang, P; Takahashi, N; Takata, ET; Tang, Q; Theret, P; Tian, X; Tozawa, N; Unnikrishnan, R; Vilela, JCS; Villa, RE; von Haeften, K; Wabnitz, H; Waly, M; Wan, KX; Wang, J; Wang, X; Wang, YF; Wang, Z; Wei, J; Wei, N; Wen, S; Westendorf, J; Worthy, FR; Woutersen, R; Wu, J; Wu, X; Xu, JC; Xu, YJ; Yakubov, S; Yamashita, T; Yan, HH; Yan, X; Yang, Y; Yoo, SH; Yu, S; Yu, T; Yu, Y; Yuan, C; Zeng, Y; Zhan, X; Zhang, H; Zhang, JM; Zhang, X; Zhao, JZ; Zhao, P; Zhao, S; Zheng, J; Zheng, XQ; Zhong, X; Zhou, YJ; Zhu, F; Zhu, J; Zinta, G; Zou, HY; Zucconi, E | 1 |
Altun, M; Bilgi Kamaç, M; Sezgintürk, MK; Yilmaz, M | 1 |
Anderson, N; Butler, A; Chitcholtan, K; Kaushik, A; Kumar, D; Lowe, C; Moghiseh, M; Mutreja, I; Raja, A; Sykes, P | 1 |
Becatti, M; Cirri, D; Gabbiani, C; Gamberi, T; Geri, A; Magherini, F; Mannelli, M; Massai, L; Messori, L; Pratesi, A | 1 |
Ramar, A; Runprapan, N; Wang, FM; Yuan, CC | 1 |
Liu, Y; Tang, Y; Xia, Y; Zeng, B; Zhao, F | 1 |
Baglini, E; Barresi, E; Chiaverini, L; Da Settimo, F; Gamberi, T; La Mendola, D; Mannelli, M; Marzo, T; Poggetti, V; Taliani, S | 1 |
Lv, H; Sun, Q; Suo, Y; Wang, Q; Yin, H | 1 |
Aktan, S; Altun, M; Bilgi Kamaç, M; Sezgintürk, MK; Yılmaz Aktan, A; Yılmaz, M | 1 |
Cotchim, S; Jiraseree-Amornkun, A; Kanatharana, P; Limbut, W; Thantipwan, T; Thavarungkul, P; Wannapob, R | 1 |
Bendas, G; Bückreiß, N; Hoffmeister, H; König, P; Ott, I; Suparman, E; Zhulenko, R | 1 |
Jiang, G; Liu, W; Liu, Y; Lu, Q; Lu, Y; Shan, M; Xu, Z; Yang, Z | 1 |
Du, Y; Huang, Q; Lan, T; Ma, C; Wang, R; Wang, S; Wei, W; Yuan, H; Zhang, Q; Zhao, Y | 1 |
Awuah, SG; Grossman, RB; Gukathasan, S; Obisesan, OA; Parkin, S; Ratliff, L; Saryazdi, S | 1 |
Ahmad, S; Aldinucci, D; Altaf, M; Borghese, C; Casagrande, N; Corona, G; Isab, AA; Peedikakkal, AMP; Sulaiman, AAA | 1 |
Susapto, HH; TunÇ, İ | 1 |
Banerjee, A; Chanda, N; Chatterjee, M; Das, A; Maity, R; Mazumder, S; Mishra, R | 1 |
Huang, R; Kou, W; Liu, J; Ma, W; Shang, L; Zhao, J | 1 |
Fathi, M; Ghanbari, H; Omidi, Y; Saber, R; Samadi Pakchin, P | 1 |
Bian, M; Fan, R; Liu, W; Liu, Y; Liu, Z; Sun, Y; Xu, Z | 1 |
He, Y; Hüttmann, G; Rahmanzadeh, R; Rudnitzki, F; Yao, C; Zhang, Z | 1 |
Almeida, M; Belo, D; Fontinha, D; Guerreiro, JF; Le Gal, Y; Leitão, JH; Lorcy, D; Marques, F; Morais, TS; Pinheiro, T; Prudêncio, M; Silva, RAL; Sousa, SA; Velho, MFG | 1 |
Bhattacharya, R; Bieniasz, M; Chinthalapally, HR; Fung, KM; Hossen, MN; Mukherjee, P; Robertson, JD; Wang, L; Wilhelm, S | 1 |
Austin, LA; Cramer, DW; Evans, CL; González, G; Hansen, WP; Ho, A; Hoballah, J; Jeong, S; Kapur, A; Krauledat, P; Mubarak, F; Nowell, N; Patankar, MS | 1 |
Bonsignore, R; Casini, A; Cichna-Markl, M; Del Favero, G; Gerner, C; Gerner, MC; Koellensperger, G; Meier-Menches, SM; Neuditschko, B; Schaier, M; Schmetterer, KG; Zappe, K | 1 |
Bardhan, NM; Belcher, AM; Hammond, PT; He, Y; Huang, S; Irvine, DJ; Iyer, AM; Li, Y; Lin, CW; Qi, J | 1 |
Astilean, S; Borlan, R; Craciun, AM; Focsan, M; Hada, AM; Soritau, O; Todea, M | 1 |
Bucki, R; Chabielska, E; Depciuch, J; Janion, M; Marcińczyk, N; Ościłowska, I; Parlinska-Wojtan, M; Piktel, E; Suprewicz, Ł; Wolak, P; Wollny, T | 1 |
Alves, JQ; Dalmolin, LF; de Albuquerque, S; Gelamo, RV; Leite, NB; Lopez, RFV; Maia, PIDS; Pereira, LM; Possato, B; Silva, RTC; Yatsuda, AP | 1 |
Cathcart, N; Kitaev, V; Maleki, A; Radmanesh, M; Taheri-Ledari, R; Zhang, W | 1 |
Ali, MRK; Chen, K; Dawson, MR; Do, BH; El-Sayed, MA; Fang, N; Ghosh, D; Sulchek, TA; Wu, Y | 1 |
Arena, F; Biffi, S; Bortot, B; Comes Franchini, M; La Cava, F; Locatelli, E; Marini, GM; Monaco, I; Severini, GM; Terreno, E | 1 |
Costa, JPC; Costa, PI; Gasparotto, G; Mazon, T; Zaghete, MA | 1 |
Bahrami, S; Fathi, F; Hamd-Ghadareh, S; Salimi, A | 1 |
Chitcholtan, K; Kumar, D; Mutreja, I; Sykes, P | 1 |
Ak, G; Güneş, A; Hamarat Sanlier, S; Yilmaz, H | 1 |
Astilean, S; Craciun, AM; Licarete, E; Suarasan, S | 1 |
Ding, Y; Nie, Y; Yang, M | 1 |
Chan, WCW; Chen, YY; Dai, Q; Ding, D; MacMillan, P; Sindhwani, S; Syed, AM; Wilhelm, S; Zhang, Y | 1 |
Hasanzadeh, M; Mahboob, S; Mokhtarzadeh, A; Sahmani, R; Shadjou, N; Solhi, E | 1 |
Ghanbari, H; Omidi, Y; Saber, R; Samadi Pakchin, P | 1 |
Astilean, S; Hada, AM; Licarete, E; Nagy-Simon, T; Potara, M; Suarasan, S; Vulpoi, A | 1 |
Bhattacharya, R; Dey, A; Elechalawar, CK; Hossen, MN; Huai, Y; Mukherjee, P; Rao, G; Roy, RV; Xiong, X; Zhang, Y | 1 |
Li, P; Liu, S; Liu, Y; Wang, D; Wei, W; Yang, H; Zhang, Y | 1 |
Arvizo, RR; Bhattacharya, R; Mukherjee, P; Robertson, JD; Saha, S; Wang, E | 1 |
Arvizo, RR; Bhattacharya, R; Moyano, DF; Mukherjee, P; Prakash, YS; Rotello, VM; Saha, S; Thompson, MA | 1 |
Bagley, AF; Bhatia, SN; Hill, S; Rogers, GS | 1 |
Adjei, AA; Erlichman, C; Fields, AP; Jatoi, A; Mansfield, AS; Molina, JR; Qi, Y | 1 |
Elzey, BD; Jeon, M; Kim, C; Mehtala, JG; Torregrosa-Allen, S; Wei, A | 1 |
Gabbiani, C; Guerri, A; Landini, I; Leoni, P; Marchetti, L; Massai, L; Messori, L; Mini, E; Nobili, S; Pasquali, M; Perrone, G; Scaletti, F | 1 |
Arvizo, RR; Bhattacharya, R; Chakraborty, PK; Giri, K; Kocher, JP; Madden, BJ; Mccormick, DJ; Mukherjee, P; Saha, S; Shameer, K; Sharma, A; Zimmermann, MT | 1 |
Hayashi, R; Kitajima, T; Kodama, H; Nakatsui, K; Oohara, N; Osada, S; Sugiya, M; Sugiyama, D | 1 |
Orsinger, GV; Romanowski, M; Williams, JD | 1 |
Li, C; Liang, D; Liu, Y; Robertson, JD; Van Pelt, C; You, J; Zhou, J; Zhou, M | 1 |
Arvizo, RR; Bhattacharya, R; McMeekin, S; Mukherjee, P; Robertson, DJ; Saha, S; Xiong, X | 1 |
Centi, S; Fusi, F; Gnerucci, A; Landini, I; Marrazza, G; Mercatelli, R; Mini, E; Nobili, S; Pini, R; Ratto, F; Ravalli, A; Romano, G; Tatini, F | 1 |
Aghaie, M; Barar, J; Coukos, G; Johari-Ahar, M; Karami, P; Mohammadnejad, D; Omidi, Y; Ramazani, A; Rashidi, MR | 1 |
Akbarzadeh, A; Kafshdooz, L; Kafshdooz, T; Razban, Z | 1 |
Dai, J; Hao, Y; Li, Q; Lin, S; Liu, W; Shuai, X; Zhang, C | 1 |
Chang, CL; Hsu, YT; Huang, JT; Hung, CF; Wu, CC; Wu, TC; Yang, YC | 1 |
Haick, H; Kahn, N; Lavie, O; Paz, M; Segev, Y | 1 |
Cai, H; Li, D; Li, M; Ng, SW; Sun, RW; Wong, AS; Xian, YJ; Zhang, M; Zhang, ZF | 1 |
Li, D; Li, M; Sun, RW; Wong, AS; Zhang, M | 1 |
Chen, Y; Guo, Y; Qi, L; Shi, D; Tong, X; Tu, K; Wang, J; Wu, W; Xu, M | 1 |
D'Hollander, A; Devoogdt, N; Himmelreich, U; Jans, H; Lagae, L; Massa, S; Muyldermans, S; Stakenborg, T; Velde, GV; Verstraete, C | 1 |
Kneipp, J | 1 |
Avasthi, DK; Gohil, NK; Kabiraj, D; Mishra, YK; Mohanta, B; Mohapatra, S; Singh, N; Singhal, R | 1 |
Huo, Q | 1 |
Ghandehari, H; Janát-Amsbury, MM; Peterson, CM; Ray, A | 1 |
Chen, J; Geng, F; Kong, B; Song, K; Xing, JZ; Yan, S; Yang, Q; Yuan, C | 1 |
Casini, A; Cerrada, E; Clavel, C; Laguna, M; Vergara, E | 1 |
Ontko, AC; Palanichamy, K; Sreejayan, N | 1 |
Delerue-Matos, C; Rani, C; Ribeiro, S; Viswanathan, S | 1 |
Ju, H; Wang, C; Wu, J; Yan, F; Zong, C | 1 |
Arvizo, RR; Bhattacharya, R; Giri, K; Kocher, JP; Madden, B; McCormick, DJ; Miranda, OR; Moyano, D; Mukherjee, P; Rotello, VM | 1 |
Pearson, S; Scarano, W; Stenzel, MH | 1 |
Balandin, TG; Deyev, SM; Edelweiss, EF; Ivanova, JL; Leonova, OG; Popenko, VI | 1 |
Delerue-Matos, C; Rani, C; Viswanathan, S | 1 |
Cole, AJ; Gambhir, SS; Jokerst, JV; Van de Sompel, D | 1 |
Hauser, GA; Tapia, JE; von Felten, A | 1 |
Frischkorn, R; Joswig, EH; Joswig-Priewe, H; Vahrson, H | 1 |
Cernoch, A | 1 |
Vad'ura, F | 1 |
Kazár, A; Kunstadt, E | 1 |
3 review(s) available for gold and Ovarian Neoplasms
Article | Year |
---|---|
Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies, Monoclonal, Humanized; Antibodies, Protozoan; Anxiety; Apoptosis; Arabidopsis; Arabidopsis Proteins; ATP Binding Cassette Transporter, Subfamily B; bcl-2-Associated X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brain-Derived Neurotrophic Factor; Calcitonin; Calcium Channels, N-Type; Capsaicin; Carbon Dioxide; Carcinoma, Neuroendocrine; Case-Control Studies; Cats; Cell Line, Tumor; Child; China; Cholangiocarcinoma; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Coculture Techniques; Cognition; COVID-19; Cross-Sectional Studies; Diagnostic Imaging; Dried Blood Spot Testing; Droughts; Dyslipidemias; East Asian People; Endocytosis; Ethanol; Female; Flavonoids; Ganglia, Spinal; Gastric Mucosa; Gene Expression Regulation, Plant; Genital Neoplasms, Female; Glucosinolates; Gold; Health Status; Humans; Hydrogen; Hypoparathyroidism; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Individuality; Internet Addiction Disorder; Isopropyl Thiogalactoside; Lactams; Leg; Light; Lupus Erythematosus, Systemic; Lymph Node Excision; Male; Mammals; Mice; Microscopy; Middle Aged; Muscle Proteins; Muscle, Skeletal; Nanotubes; Neoplasms; NF-kappa B; Nuclear Receptor Subfamily 1, Group D, Member 1; Obesity; Outcome Assessment, Health Care; Ovarian Neoplasms; Pandemics; Parathyroid Glands; Philadelphia Chromosome; Polymorphism, Single Nucleotide; Posture; Powders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prevalence; Prognosis; Quadriceps Muscle; Quality of Life; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Retrospective Studies; Risk Factors; Saudi Arabia; Seroepidemiologic Studies; Spinal Cord; Stomach Ulcer; Students; Sulfhydryl Compounds; Surface Plasmon Resonance; Tandem Mass Spectrometry; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Toll-Like Receptor 4; Toxoplasma; Toxoplasmosis; Transcriptome; Treatment Outcome; Triglycerides; TRPV Cation Channels; Tumor Microenvironment; Tumor Suppressor Protein p53; Ultrasonography, Interventional; Universities; Zebrafish | 2023 |
Electrochemical immunosensor based on ZnO nanorods-Au nanoparticles nanohybrids for ovarian cancer antigen CA-125 detection.
Topics: Biosensing Techniques; CA-125 Antigen; Electrochemical Techniques; Female; Gold; Humans; Immunoassay; Metal Nanoparticles; Nanotubes; Ovarian Neoplasms; Reproducibility of Results | 2017 |
The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer.
Topics: Animals; Breast Neoplasms; Female; Gold; Humans; Metal Nanoparticles; Ovarian Neoplasms | 2016 |
2 trial(s) available for gold and Ovarian Neoplasms
Article | Year |
---|---|
Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies, Monoclonal, Humanized; Antibodies, Protozoan; Anxiety; Apoptosis; Arabidopsis; Arabidopsis Proteins; ATP Binding Cassette Transporter, Subfamily B; bcl-2-Associated X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brain-Derived Neurotrophic Factor; Calcitonin; Calcium Channels, N-Type; Capsaicin; Carbon Dioxide; Carcinoma, Neuroendocrine; Case-Control Studies; Cats; Cell Line, Tumor; Child; China; Cholangiocarcinoma; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Coculture Techniques; Cognition; COVID-19; Cross-Sectional Studies; Diagnostic Imaging; Dried Blood Spot Testing; Droughts; Dyslipidemias; East Asian People; Endocytosis; Ethanol; Female; Flavonoids; Ganglia, Spinal; Gastric Mucosa; Gene Expression Regulation, Plant; Genital Neoplasms, Female; Glucosinolates; Gold; Health Status; Humans; Hydrogen; Hypoparathyroidism; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Individuality; Internet Addiction Disorder; Isopropyl Thiogalactoside; Lactams; Leg; Light; Lupus Erythematosus, Systemic; Lymph Node Excision; Male; Mammals; Mice; Microscopy; Middle Aged; Muscle Proteins; Muscle, Skeletal; Nanotubes; Neoplasms; NF-kappa B; Nuclear Receptor Subfamily 1, Group D, Member 1; Obesity; Outcome Assessment, Health Care; Ovarian Neoplasms; Pandemics; Parathyroid Glands; Philadelphia Chromosome; Polymorphism, Single Nucleotide; Posture; Powders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prevalence; Prognosis; Quadriceps Muscle; Quality of Life; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Retrospective Studies; Risk Factors; Saudi Arabia; Seroepidemiologic Studies; Spinal Cord; Stomach Ulcer; Students; Sulfhydryl Compounds; Surface Plasmon Resonance; Tandem Mass Spectrometry; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Toll-Like Receptor 4; Toxoplasma; Toxoplasmosis; Transcriptome; Treatment Outcome; Triglycerides; TRPV Cation Channels; Tumor Microenvironment; Tumor Suppressor Protein p53; Ultrasonography, Interventional; Universities; Zebrafish | 2023 |
Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Female; Gold; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Isoenzymes; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Pancreatic Neoplasms; Protein Kinase C | 2013 |
97 other study(ies) available for gold and Ovarian Neoplasms
Article | Year |
---|---|
Yolk-Shell-Type Gold Nanoaggregates for Chemo- and Photothermal Combination Therapy for Drug-Resistant Cancers.
Topics: Animals; Antibiotics, Antineoplastic; Cell Death; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Ovarian Neoplasms; Particle Size; Photothermal Therapy; Surface Properties; Tumor Cells, Cultured | 2021 |
A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gold; Humans; Mice; Mice, Nude; MicroRNAs; Nanoparticles; Nanostructures; Nanotubes; Ovarian Neoplasms; Paclitaxel; Signal Transduction; Silicon Dioxide; TOR Serine-Threonine Kinases | 2021 |
Triple-combination therapy assisted with ultrasound-active gold nanoparticles and ultrasound therapy against 3D cisplatin-resistant ovarian cancer model.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Gold; Humans; Metal Nanoparticles; Ovarian Neoplasms; Pharmaceutical Preparations; Xenograft Model Antitumor Assays | 2022 |
Molybdenum Disulfide Supported on Metal-Organic Frameworks as an Ultrasensitive Layer for the Electrochemical Detection of the Ovarian Cancer Biomarker CA125.
Topics: Biomarkers, Tumor; CA-125 Antigen; Disulfides; Electrochemical Techniques; Female; Gold; Humans; Metal Nanoparticles; Metal-Organic Frameworks; Molybdenum; Ovarian Neoplasms | 2021 |
Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer.
Topics: Algorithms; Antibodies; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorescent Dyes; Gold; Humans; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocyte Count; Membrane Proteins; Microscopy, Fluorescence; Monocytes; Nanoparticles; Natural Killer T-Cells; Neoplasm Grading; Ovarian Neoplasms; Platelet Count | 2022 |
Rapid and ultrasensitive electrochemical detection of DNA methylation for ovarian cancer diagnosis.
Topics: Biosensing Techniques; Cytosine; DNA; DNA Methylation; Electrochemical Techniques; Gold; Humans; Metal Nanoparticles; Ovarian Neoplasms | 2022 |
Multifunctional Human Serum Albumin Fusion Protein as a Docetaxel Nanocarrier for Chemo-photothermal Synergetic Therapy of Ovarian Cancer.
Topics: Cell Line, Tumor; Docetaxel; Female; Gold; Histidine; Humans; Metal Nanoparticles; Nanoparticles; Oligopeptides; Ovarian Neoplasms; Recombinant Proteins; Serum Albumin, Human | 2022 |
The effects of two gold-N-heterocyclic carbene (NHC) complexes in ovarian cancer cells: a redox proteomic study.
Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Coordination Complexes; Female; Gold; Gold Compounds; Humans; Methane; Ovarian Neoplasms; Oxidation-Reduction; Proteomics | 2022 |
Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Female; Gold; Heterocyclic Compounds; Humans; Ligands; Methane; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; Silver; Thioredoxin-Disulfide Reductase | 2022 |
An Interfacial Affinity Interaction-Based Method for Detecting HOTAIR lncRNA in Cancer Plasma Samples.
Topics: Apoptosis; Cell Line, Tumor; Female; Genes, Homeobox; Gold; Humans; MicroRNAs; Ovarian Neoplasms; RNA, Antisense; RNA, Long Noncoding | 2022 |
Multiparametric cytotoxicity assessment: the effect of gold nanoparticle ligand functionalization on SKOV3 ovarian carcinoma cell death.
Topics: Cell Death; Female; Gold; Humans; Ligands; Metal Nanoparticles; Ovarian Neoplasms; Polyethylene Glycols | 2022 |
Surface Plasmon Enhanced Upconversion Fluorescence in Short-Wave Infrared for In Vivo Imaging of Ovarian Cancer.
Topics: Diagnostic Imaging; Female; Fluorescence; Fluorescent Dyes; Gold; Humans; Ovarian Neoplasms | 2022 |
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.
Topics: Antineoplastic Agents; Auranofin; Cell Line, Tumor; Female; Gold; Humans; Ovarian Neoplasms | 2022 |
Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth.
Topics: Animals; Female; Gold; Humans; Insulin; Metal Nanoparticles; Ovarian Neoplasms; PTEN Phosphohydrolase; Tissue Distribution; TOR Serine-Threonine Kinases | 2022 |
A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)
Topics: Aged; Antibodies, Monoclonal; Calcium Hydroxide; Docetaxel; Female; Gold; Humans; Immunoglobulin G; Magnetic Phenomena; Metal Nanoparticles; Ovarian Neoplasms; Polyvinyl Alcohol | 2022 |
Biogenic synthesis of gold nanoparticles using Satureja rechingeri Jamzad: a potential anticancer agent against cisplatin-resistant A2780CP ovarian cancer cells.
Topics: Antineoplastic Agents; Cisplatin; Female; Gold; Green Chemistry Technology; Humans; Metal Nanoparticles; Ovarian Neoplasms; Plant Extracts; Satureja | 2023 |
Sensitive electrochemical detection of polymorphisms in IL6 and TGFβ1 genes from ovarian cancer DNA patients using EcoRI and DNA hairpin-modified gold electrodes.
Topics: Deoxyribonuclease EcoRI; DNA; DNA Mutational Analysis; Electrodes; Female; Gold; Humans; Interleukin-6; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Transforming Growth Factor beta1 | 2022 |
A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer.
Topics: Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Early Detection of Cancer; Electrochemical Techniques; Female; Gold; Humans; Immunoassay; Metal Nanoparticles; Ovarian Neoplasms; Proteins | 2023 |
LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated
Topics: Contrast Media; Female; Gold; Gonadotropin-Releasing Hormone; Humans; Metal Nanoparticles; Ovarian Neoplasms; Tomography, X-Ray Computed | 2023 |
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
Topics: Antineoplastic Agents; Auranofin; Cell Line, Tumor; Female; Gold; Humans; Ligands; Ovarian Neoplasms; Phosphites | 2023 |
Role of Defects of Carbon Nanomaterials in the Detection of Ovarian Cancer Cells in Label-Free Electrochemical Immunosensors.
Topics: Biosensing Techniques; Electrochemical Techniques; Electrodes; Female; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Nanotubes, Carbon; Ovarian Neoplasms | 2023 |
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL.
Topics: Biosensing Techniques; Electrochemical Techniques; Female; Gold; Humans; Hydrogen Peroxide; Immunoassay; Limit of Detection; Luminescent Measurements; Metal Nanoparticles; Ovarian Neoplasms; Quantum Dots | 2023 |
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt
Topics: Antineoplastic Agents; Auranofin; Cell Line, Tumor; Female; Gold; Humans; Ligands; Ovarian Neoplasms; Pharmacophore; Receptors, GABA; Thioredoxin-Disulfide Reductase | 2023 |
Porphin e6 complex loaded with gold nanorod mesoporous silica enhances photodynamic therapy in ovarian cancer cells in vitro.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Chlorophyllides; Female; Gold; Humans; Nanotubes; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Poly(ADP-ribose) Polymerase Inhibitors; Porphyrins; Reactive Oxygen Species; Silicon Dioxide | 2023 |
Point-of-care testing: a disposable label-free electrochemical CA125 and HE4 immunosensors for early detection of ovarian cancer.
Topics: Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Early Detection of Cancer; Female; Gold; Humans; Immunoassay; Metal Nanoparticles; Ovarian Neoplasms; Point-of-Care Systems; Proteins | 2023 |
A portable electrochemical immunosensor for ovarian cancer uses hierarchical microporous carbon material from waste coffee grounds.
Topics: Biosensing Techniques; Carbon; Coffee; Electrochemical Techniques; Female; Gold; Humans; Immunoassay; Metal Nanoparticles; Ovarian Neoplasms | 2023 |
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Auranofin; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Gold; Humans; NF-E2-Related Factor 2; Ovarian Neoplasms; Prospective Studies | 2023 |
NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer.
Topics: B7-H1 Antigen; Cell Line, Tumor; Female; Gold; Humans; Immunity; Inflammation; Ovarian Neoplasms; Reactive Oxygen Species | 2023 |
Fabrication of a Novel Au Star@AgAu Yolk-Shell Nanostructure for Ovarian Cancer Early Diagnosis and Targeted Therapy.
Topics: Early Detection of Cancer; Female; Gold; Humans; Nanostructures; Ovarian Neoplasms; Silicon Dioxide; Spectrum Analysis, Raman | 2023 |
A Conformationally Restricted Gold(III) Complex Elicits Antiproliferative Activity in Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Diamines; Female; Gold; Humans; Ligands; Norbornanes; Ovarian Neoplasms | 2023 |
Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Female; Gold; Humans; Ligands; Lung; Lung Neoplasms; Male; Ovarian Neoplasms; Proteasome Endopeptidase Complex; Spectroscopy, Fourier Transform Infrared; Stem Cells | 2023 |
Label-Free Detection of Ovarian Cancer Antigen CA125 by Surface Enhanced Raman Scattering.
Topics: Female; Gold; Humans; Metal Nanoparticles; Ovarian Neoplasms; Spectrum Analysis, Raman | 2020 |
Gold nanoparticle-assisted enhancement in the anti-cancer properties of theaflavin against human ovarian cancer cells.
Topics: Apoptosis; Biflavonoids; Biomarkers, Tumor; Catechin; Cell Line, Tumor; Cell Survival; Endocytosis; Female; Gold; Hemolysis; Humans; Membrane Potential, Mitochondrial; Metal Nanoparticles; Ovarian Neoplasms; Photoelectron Spectroscopy; Reactive Oxygen Species | 2019 |
Poly-amino acids coated gold nanorod and doxorubicin for synergistic photodynamic therapy and chemotherapy in ovarian cancer cells.
Topics: Cell Line, Tumor; Coated Materials, Biocompatible; Doxorubicin; Female; Gold; Humans; Metal Nanoparticles; Nanotubes; Ovarian Neoplasms; Photochemotherapy; Polyglutamic Acid; Polylysine | 2019 |
A novel electrochemical immunosensor for ultrasensitive detection of CA125 in ovarian cancer.
Topics: Antibodies, Immobilized; Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Chitosan; Electric Conductivity; Electrochemical Techniques; Electrodes; Female; Gold; Graphite; Humans; Immunoassay; Limit of Detection; Membrane Proteins; Metal Nanoparticles; Nanotubes, Carbon; Ovarian Neoplasms; Polyamines; Surface Properties | 2020 |
A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti-Ovarian-Cancer Agent by Inhibiting TrxR and Activating ROS-Mediated ERS.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Coordination Complexes; Endoplasmic Reticulum Stress; Female; Gold; Humans; Oleanolic Acid; Ovarian Neoplasms; Oxidation-Reduction; Reactive Oxygen Species; Thioredoxin-Disulfide Reductase | 2020 |
Cancer cell-specific protein delivery by optoporation with laser-irradiated gold nanorods.
Topics: Apoptosis; Cell Line, Tumor; Female; Gold; Humans; Lasers; Nanotubes; Ovarian Neoplasms | 2020 |
Gold(iii) bis(dithiolene) complexes: from molecular conductors to prospective anticancer, antimicrobial and antiplasmodial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Female; Gold; Humans; Microbial Sensitivity Tests; Ovarian Neoplasms; Plasmodium berghei; Prospective Studies; Spectrometry, Fluorescence; Staphylococcus aureus; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2020 |
Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome.
Topics: Cell Line, Tumor; Gold; Humans; Liposomes; Metal Nanoparticles; Nanoparticles; Ovarian Neoplasms; RNA, Small Interfering | 2020 |
Plasmonic Nanoparticle-Based Digital Cytometry to Quantify MUC16 Binding on the Surface of Leukocytes in Ovarian Cancer.
Topics: Apoptosis; CA-125 Antigen; Cell Line, Tumor; Female; Gold; Humans; Leukocytes, Mononuclear; Membrane Proteins; Metal Nanoparticles; Ovarian Neoplasms | 2020 |
An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Caffeine; Cell Line, Tumor; Female; Gold; Humans; Methane; Organometallic Compounds; Ovarian Neoplasms; Proteomics | 2020 |
Surface Plasmon-Enhanced Short-Wave Infrared Fluorescence for Detecting Sub-Millimeter-Sized Tumors.
Topics: Animals; Biocompatible Materials; Biomedical Enhancement; Cell Line, Tumor; Female; Fluorescent Dyes; Gold; Humans; Infrared Rays; Luciferases; Mice, Nude; Nanotubes; Optical Imaging; Ovarian Neoplasms; Polymers; Radio Waves; Surface Properties; Tissue Distribution | 2021 |
Folic acid functionalized gold nanoclusters for enabling targeted fluorescence imaging of human ovarian cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Female; Folic Acid; Gold; Humans; Metal Nanoparticles; Optical Imaging; Ovarian Neoplasms | 2021 |
ROS-Mediated Apoptosis and Autophagy in Ovarian Cancer Cells Treated with Peanut-Shaped Gold Nanoparticles.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Arachis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Female; Gold; Humans; MAP Kinase Signaling System; Metal Nanoparticles; Ovarian Neoplasms; Oxidation-Reduction; Reactive Oxygen Species | 2021 |
Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: Cytotoxicity and interactions with biomolecular targets.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Female; Gold; Humans; Ligands; Ovarian Neoplasms | 2021 |
Plasmonic photothermal release of docetaxel by gold nanoparticles incorporated onto halloysite nanotubes with conjugated 2D8-E3 antibodies for selective cancer therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Clay; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Gold; Humans; Metal Nanoparticles; Nanocomposites; Nanotubes; Neoplasms; Ovarian Neoplasms; Particle Size | 2021 |
Nuclear Membrane-Targeted Gold Nanoparticles Inhibit Cancer Cell Migration and Invasion.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Nucleus; Drug Screening Assays, Antitumor; Female; Gold; Humans; Metal Nanoparticles; Microscopy, Atomic Force; Ovarian Neoplasms; Particle Size; Tumor Cells, Cultured | 2017 |
Synthesis of Lipophilic Core-Shell Fe
Topics: Animals; Cell Proliferation; Female; Ferric Compounds; Folic Acid; Gold; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Multimodal Imaging; Ovarian Neoplasms; Photoacoustic Techniques; Polymers; Silicon Dioxide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
An amplified comparative fluorescence resonance energy transfer immunosensing of CA125 tumor marker and ovarian cancer cells using green and economic carbon dots for bio-applications in labeling, imaging and sensing.
Topics: Antibodies, Immobilized; Aptamers, Nucleotide; Biosensing Techniques; CA-125 Antigen; Carbon; Cell Line, Tumor; Dendrimers; Female; Fluorescence Resonance Energy Transfer; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Optical Imaging; Ovarian Neoplasms; Ovary | 2017 |
Cytotoxicity and cellular uptake of different sized gold nanoparticles in ovarian cancer cells.
Topics: Cell Death; Cell Line, Tumor; DNA, Neoplasm; Endocytosis; Female; Gold; Humans; Metal Nanoparticles; Microscopy, Fluorescence; Ovarian Neoplasms; Particle Size; Reactive Oxygen Species | 2017 |
In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy.
Topics: Animals; Biological Transport; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Female; Folic Acid Transporters; Gold; Hemolysis; Humans; Macrophages; Magnets; Metal Nanoparticles; Mice; Molecular Targeted Therapy; Ovarian Neoplasms; Tissue Distribution | 2018 |
Probing cellular uptake and tracking of differently shaped gelatin-coated gold nanoparticles inside of ovarian cancer cells by two-photon excited photoluminescence analyzed by fluorescence lifetime imaging (FLIM).
Topics: Cell Line, Tumor; Female; Gelatin; Gold; Humans; Metal Nanoparticles; Microscopy, Fluorescence; Optical Imaging; Ovarian Neoplasms; Photons | 2018 |
Gold nanoparticle enhanced hybridization chain reaction as a method for signal amplification. Application to electrochemical immunodetection of the ovarian cancer biomarker carbohydrate antigen 125.
Topics: Biomarkers, Tumor; CA-125 Antigen; Electrochemical Techniques; Female; Gold; Humans; Immunoassay; Metal Nanoparticles; Nucleic Acid Hybridization; Ovarian Neoplasms | 2018 |
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors.
Topics: Animals; Antineoplastic Agents, Immunological; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Female; Gold; Humans; Ligands; Mice; Nanoparticles; Neoplasms, Experimental; Ovarian Neoplasms; Silicon Dioxide; Trastuzumab | 2018 |
Ultrasensitive immunoassay of carcinoma antigen 125 in untreated human plasma samples using gold nanoparticles with flower like morphology: A new platform in early stage diagnosis of ovarian cancer and efficient management.
Topics: Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Early Detection of Cancer; Electrochemical Techniques; Female; Gold; Humans; Immunoassay; Kinetics; Metal Nanoparticles; Neoplasm Staging; Ovarian Neoplasms; Sensitivity and Specificity | 2018 |
Electrochemical immunosensor based on chitosan-gold nanoparticle/carbon nanotube as a platform and lactate oxidase as a label for detection of CA125 oncomarker.
Topics: Antibodies, Immobilized; Biosensing Techniques; CA-125 Antigen; Chitosan; Electrochemical Techniques; Female; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Mixed Function Oxygenases; Nanotubes, Carbon; Ovarian Neoplasms | 2018 |
Fabrication of gold-silver core-shell nanoparticles for performing as ultrabright SERS-nanotags inside human ovarian cancer cells.
Topics: Benzoates; Cell Line, Tumor; Female; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Ovarian Neoplasms; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds | 2019 |
Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro.
Topics: Cell Movement; Endothelial Cells; Female; Gold; Humans; Metal Nanoparticles; Neovascularization, Pathologic; Ovarian Neoplasms; Signal Transduction; Tumor Cells, Cultured; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Quartz Crystal Microbalance Detection of Poly(ADP-ribose) Polymerase-1 Based on Gold Nanorods Signal Amplification.
Topics: Adenosine Diphosphate Ribose; Biomarkers, Tumor; Cell Line, Tumor; Cetrimonium; Female; Gold; Humans; Limit of Detection; NAD; Nanotubes; Neoplasm Proteins; Niacinamide; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly Adenosine Diphosphate Ribose; Quartz Crystal Microbalance Techniques; Static Electricity | 2019 |
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle.
Topics: Blotting, Western; Cadherins; Cell Proliferation; Drug Delivery Systems; Epithelial-Mesenchymal Transition; Female; Gold; Humans; Immunohistochemistry; MAP Kinase Signaling System; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Neoplasm Metastasis; Ovarian Neoplasms; Real-Time Polymerase Chain Reaction; Snail Family Transcription Factors; Transcription Factors; Vimentin | 2013 |
Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Calcium-Binding Proteins; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Female; Gene Expression; Gene Knockdown Techniques; Gold; Humans; Membrane Potential, Mitochondrial; Metal Nanoparticles; Mitochondria; Mitochondrial Membrane Transport Proteins; Ovarian Neoplasms | 2013 |
Plasmonic photothermal heating of intraperitoneal tumors through the use of an implanted near-infrared source.
Topics: Animals; Cell Line, Tumor; Equipment Design; Equipment Failure Analysis; Female; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Metal Nanoparticles; Mice; Ovarian Neoplasms; Phototherapy; Prostheses and Implants; Surface Plasmon Resonance; Treatment Outcome | 2013 |
Synergistic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Drug Synergism; Female; Gold; Humans; Hyperthermia, Induced; Nanotubes; Ovarian Neoplasms | 2014 |
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Female; Gold; Humans; Methane; Molecular Structure; Ovarian Neoplasms | 2014 |
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics.
Topics: Antineoplastic Agents; Cell Proliferation; Computational Biology; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gold; Humans; Metal Nanoparticles; Models, Molecular; Neoplasm Proteins; Ovarian Neoplasms; Particle Size; Proteomics; Structure-Activity Relationship; Surface Properties; Tumor Cells, Cultured | 2014 |
Anti-tumor activities of Au(I) complexed with bisphosphines in HL-60 cells.
Topics: Apoptosis; Carbamates; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Gold; HL-60 Cells; Humans; Ovarian Neoplasms; Pyrrolizidine Alkaloids | 2014 |
Focal activation of cells by plasmon resonance assisted optical injection of signaling molecules.
Topics: Adenosine; Calcium; Cell Line; Cell Line, Tumor; Female; Gap Junctions; Gold; Humans; Inositol 1,4,5-Trisphosphate; Liposomes; Metal Nanoparticles; Nanotechnology; Optics and Photonics; Ovarian Neoplasms; Signal Transduction; Surface Plasmon Resonance | 2014 |
Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Complement Activation; Copper Radioisotopes; Female; Gold; Humans; Liver; LLC-PK1 Cells; Lung; Male; Metal Nanoparticles; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanospheres; Ovarian Neoplasms; Particle Size; Platelet Aggregation; Polyethylene Glycols; Spleen; Swine; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles.
Topics: Animals; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Down-Regulation; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Gold; Humans; Metal Nanoparticles; Mice; Mice, Nude; Nanoparticles; Ovarian Neoplasms; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
In vitro assessment of antibody-conjugated gold nanorods for systemic injections.
Topics: Animals; Antibodies; Antineoplastic Agents; CA-125 Antigen; Cell Line, Tumor; Cetrimonium; Cetrimonium Compounds; Drug Evaluation, Preclinical; Erythrocytes; Female; Gold; Humans; Immunoblotting; Injections, Intravenous; Macrophages; Membrane Proteins; Mice; Nanotubes; Ovarian Neoplasms | 2014 |
An ultra-sensitive impedimetric immunosensor for detection of the serum oncomarker CA-125 in ovarian cancer patients.
Topics: Amines; Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Cadmium Compounds; Dielectric Spectroscopy; Female; Gold; Humans; Limit of Detection; Membrane Proteins; Metal Nanoparticles; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Nanotechnology; Ovarian Neoplasms; Propionates; Selenium Compounds; Silicon Dioxide | 2015 |
Synthesis and characterization of cell-microenvironment-sensitive leakage-free gold-shell nanoparticles with the template of interlayer-crosslinked micelles.
Topics: Antineoplastic Agents; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Female; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Micelles; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Microenvironment | 2015 |
Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer.
Topics: Animals; Antibodies, Monoclonal; CD47 Antigen; Female; Gold; Hot Temperature; Humans; Hyperthermia, Induced; Infrared Rays; Lasers; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Nanoshells; Ovarian Neoplasms; Peritoneum; Phototherapy; Surface Plasmon Resonance | 2015 |
Dynamic Nanoparticle-Based Flexible Sensors: Diagnosis of Ovarian Carcinoma from Exhaled Breath.
Topics: Breath Tests; Female; Gold; Humans; Metal Nanoparticles; Ovarian Neoplasms; Volatile Organic Compounds | 2015 |
Dinuclear Gold(I) Pyrrolidinedithiocarbamato Complex: Cytotoxic and Antimigratory Activities on Cancer Cells and the Use of Metal-Organic Framework.
Topics: Cell Line; Cisplatin; Female; Gold; Gold Compounds; Humans; Ligands; Molecular Structure; Ovarian Neoplasms; Thiocarbamates; Zinc | 2015 |
Enhanced anti-cancer activities of a gold(III) pyrrolidinedithiocarbamato complex incorporated in a biodegradable metal-organic framework.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Gold; Humans; Ovarian Neoplasms; Pyrrolidines; Thiocarbamates | 2016 |
Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle.
Topics: Aptamers, Nucleotide; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gold; Humans; Magnetite Nanoparticles; Neoplasm Proteins; Ovarian Neoplasms; Vascular Endothelial Growth Factor A | 2017 |
Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars.
Topics: Animals; Cell Line, Tumor; CHO Cells; Cricetulus; Drug Delivery Systems; Female; Gold; Humans; Mercaptoethanol; Metal Nanoparticles; Ovarian Neoplasms; Protein Corona; Receptor, ErbB-2; Single-Domain Antibodies; Theranostic Nanomedicine; Treatment Outcome | 2017 |
Interrogating Cells, Tissues, and Live Animals with New Generations of Surface-Enhanced Raman Scattering Probes and Labels.
Topics: Animals; Female; Gold; Metal Nanoparticles; Molecular Imaging; Ovarian Neoplasms; Silver; Spectrum Analysis, Raman; Surface Properties | 2017 |
Synthesis of plasmonic nanocomposites for diverse applications.
Topics: Cell Line, Tumor; Contrast Media; Crystallization; Female; Gold; Humans; Macromolecular Substances; Materials Testing; Molecular Conformation; Nanostructures; Nanotechnology; Ovarian Neoplasms; Particle Size; Silicon Dioxide; Surface Plasmon Resonance; Surface Properties; Zinc Oxide | 2010 |
Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Antibodies; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Colonic Neoplasms; Diagnosis, Differential; Female; Gold; Humans; Immunoassay; Male; Membrane Proteins; Metal Nanoparticles; Middle Aged; Neoplasms; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Binding; Protein Conformation; Protein Tyrosine Phosphatases; Proteins; Sensitivity and Specificity | 2010 |
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages.
Topics: Animals; Biological Transport; Cell Line; Female; Gold; Injections, Intravenous; Macrophages; Metal Nanoparticles; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanotubes; Ovarian Neoplasms; Particle Size; Polyethylene Glycols; Protein Binding; Serum Albumin, Bovine; Surface Properties; Tissue Distribution | 2011 |
Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer.
Topics: Cell Cycle; Cell Death; Cell Line, Tumor; Female; Flow Cytometry; Fluorescence; Glucose; Gold; Humans; Intracellular Space; Metal Nanoparticles; Ovarian Neoplasms; Radiation Tolerance; Reactive Oxygen Species; Sulfhydryl Compounds; X-Rays | 2011 |
Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Drug Resistance, Neoplasm; Female; Gold; Humans; Ligands; Molecular Conformation; Ovarian Neoplasms; Phosphines; Water | 2011 |
Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cell Survival; Circular Dichroism; Cisplatin; DNA Adducts; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Gold; Humans; Inhibitory Concentration 50; Molecular Mimicry; Molecular Structure; Organometallic Compounds; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2012 |
Molecular imprinted nanoelectrodes for ultra sensitive detection of ovarian cancer marker.
Topics: Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Calibration; Electrodes; Female; Gold; Humans; Limit of Detection; Metal Nanoparticles; Molecular Imprinting; Ovarian Neoplasms | 2012 |
Chemiluminescence imaging immunoassay of multiple tumor markers for cancer screening.
Topics: alpha-Fetoproteins; Antibodies; Antibodies, Immobilized; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Gold; Horseradish Peroxidase; Humans; Immunoassay; Liver Neoplasms; Luminescent Measurements; Metal Nanoparticles; Neoplasms; Ovarian Neoplasms | 2012 |
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles.
Topics: Cell Line, Tumor; Cell Proliferation; Coated Materials, Biocompatible; Female; Gene Silencing; Gold; Humans; Intercellular Signaling Peptides and Proteins; Metal Nanoparticles; Neoplasm Proteins; Ovarian Neoplasms; RNA, Small Interfering | 2012 |
Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents.
Topics: Antineoplastic Agents; Auranofin; Cell Line, Tumor; Drug Delivery Systems; Female; Gold; Humans; Magnetic Resonance Spectroscopy; Micelles; Molecular Structure; Organometallic Compounds; Ovarian Neoplasms | 2012 |
Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells.
Topics: Antibodies, Monoclonal; Bacterial Proteins; Breast Neoplasms; Cell Line, Tumor; Coated Pits, Cell-Membrane; Coated Vesicles; Endosomes; Female; Gold; Humans; Multivesicular Bodies; Ovarian Neoplasms; Receptor, ErbB-2; Recombinant Fusion Proteins; Ribonucleases; Staining and Labeling; Temperature | 2012 |
Ultrasensitive detection of ovarian cancer marker using immunoliposomes and gold nanoelectrodes.
Topics: Antibodies, Monoclonal; Benzoates; Biomarkers, Tumor; CA-125 Antigen; Electrochemical Techniques; Electrodes; Female; Ferrous Compounds; Gold; Humans; Immunoassay; Liposomes; Membrane Proteins; Metallocenes; Nanotechnology; Ovarian Neoplasms | 2012 |
Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice.
Topics: Animals; Cell Line, Tumor; Female; Gold; Metal Nanoparticles; Mice; Microscopy; Ovarian Neoplasms; Photoacoustic Techniques; Spectrum Analysis, Raman | 2012 |
[Low-carat gold intrauterine device for contraception 44 years in the uterus].
Topics: Aged; Diagnosis, Differential; Female; Foreign Bodies; Gold; Humans; Intrauterine Devices; Ovarian Neoplasms; Time Factors; Ultrasonography; Uterus | 1984 |
[Experience in peritoneography, for the prevention of the primary complications during intraperitoneal instillation of radiogold].
Topics: Contrast Media; Female; Gold; Humans; Iatrogenic Disease; Injections, Intraperitoneal; Ovarian Neoplasms; Peritoneal Cavity; Punctures; Radiography; Radiotherapy | 1976 |
[Surgical methods in progressive malignant ovarian tumors].
Topics: Antineoplastic Agents; Female; Gold; Humans; Hysterectomy; Methods; Ovarian Neoplasms; Radioisotope Teletherapy | 1971 |
[Actinotherapy of the ovarian neoplasms].
Topics: Female; Gold; Humans; Methods; Ovarian Neoplasms; Radioisotope Teletherapy; Ultraviolet Therapy | 1971 |
[Experiences with therapy of ovarian neoplasms during 20-year period (1951-70)].
Topics: Female; Gold; Humans; Ovarian Neoplasms; Radioisotope Teletherapy; Radiotherapy; Radiotherapy Dosage; Retrospective Studies | 1971 |